
|Articles|September 1, 2001
Ceramide-dominant barrier repair moisturizer improves AD
Washington - A ceramide-dominant barrier repair moisturizer (TriCeram) is a valuable adjuvant in the treatment of atopic dermatitis, according to the results of a study presented by University of California, San Francisco dermatology researchers at the annual meeting of the Society for Investigative Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
5

















